News Breaks |
|
|
| March 5, 2013 |
| 07:18 EDT |  | NVS | FDA Joint Committee Meeting
The Reproductive Health Drugs Advisory Committee and the Drug Safety & Risk Management Advisory Committee hold a meeting to discuss whether the benefit of calcitonin salmon for treatment of postmenopausal osteoporosis (thinning and weakening of bones that increases chances of having a broken bone) outweighs a potential risk of cancer. Calcitonin products approved for the treatment include Novartis Pharmaceuticals' Miacalcin injection.. The meeting is being held at FDA Silver Spring, Maryland offices on March 5 at 8 am. Webcast Link |
|
|
News For NVS From The Last 14 Days Check below for free stories on NVS the last two weeks. |
|
|
| May 24, 2013 |
| 08:22 EDT | | NVS | Leerink's biotech analysts hold an analyst/industry conference call
 Subscribe for More Information |
|
| May 21, 2013 |
| 07:44 EDT | | NVS | Sachs Associates to host a forum
Subscribe for More Information |
|
| 07:24 EDT | | NVS | Global Health Care to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 07:29 EDT | | NVS | Deutsche Bank to host a conference
dbAccess Asia Conference 2013 is being held in Singapore on May 20-22. |
|
| May 17, 2013 |
| 16:20 EDT |  | NVS | Novartis drug Afinitor extended time without disease progression in women
Subscribe for More Information |
|
| May 16, 2013 |
| 08:11 EDT | | NVS | Novartis says no intention of pursuing Actavis, Bloomberg reports
Subscribe for More Information |
|
| May 15, 2013 |
| 19:37 EDT |  | NVS | Novartis weighing Actavis bid, WSJ reports
Subscribe for More Information |
|
| 18:17 EDT | | NVS | Novartis weighs possible bid for Actavis, DJ reports
Subscribe for More Information |
|
| May 10, 2013 |
| 05:42 EDT | | NVS | Novartis drug Ilaris approved by FDA
Subscribe for More Information |
|
|
|
|
|
